aDepartment of Medicine ‘B’, Sheba Medical Center, Ramat Gan, Israel Over the past decade, subcutaneous formulations of anticancer drugs—originally administered intravenously—have been increasingly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback